Abstract
Background
An outcome measure to evaluate the neurological function of cervical myelopathy was proposed by the Japanese Orthopaedic Association in 1975 (JOA score), and has been widely used in Japan. However, the JOA score does not include patients’ satisfaction, disability, handicaps, or general health, which can be affected by cervical myelopathy. The purpose of this study was to develop a new outcome measure for patients with cervical myelopathy.
Methods
This study was conducted in eight university hospitals and their affiliated hospitals from February to May 2002. The questionnaire included 77 items. Forty-one questions, which were originally listed by the authors, were for evaluation of the physical function of the cervical spine and spinal cord. The Medical Outcome Study Short-Form 36-Item Health Survey (SF-36) was used to examine health-related quality of life (QOL). Patients with cervical myelopathy and healthy volunteers were recruited at each institution. After analysis of the answers from patients and volunteers, irrelevant questions using the following criteria were excluded: (1) a question 80% of answers for which were concentrated on one choice, (2) a question whose answer was highly correlated with that of other questions, (3) a question that could be explained by other questions, and (4) a question for which the distribution of the answers obtained from the patients was not different from that obtained from the normal volunteers.
Results
The patients comprised 164 men and 86 women, and the healthy volunteers 96 men and 120 women. Thirteen items from the questions about the physical functions of the cervical spine and the spinal cord and 11 items from SF-36 remained as candidates that should be included in the final outcome measure questionnaire.
Conclusion
Twenty-four questions remained as candidates for the final questionnaire. This new self-administered questionnaire might be used to evaluate the outcomes in patients with cervical myelopathy more efficiently.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Objective measurements such as health status, quality of life (QOL), patients’ satisfaction, health care costs, and return to work are currently used to evaluate outcomes of medical practice. An outcome measure to evaluate the neurological function of patients with cervical myelopathy, was first proposed by the Japanese Orthopaedic Association in 19751 (JOA score) and has been used widely in Japan. After Hirabayashi et al. reported in Spine in 1981 the surgical results of patients with ossification of the posterior longitudinal ligament in the cervical spine using the JOA score,2 the modified JOA score has been developed and used to evaluate cervical myelopathy in other countries.3–5 In the JOA score, neurological function is emphasizes and is used by medical professionals including spine surgeons. However, the JOA score has several problems when used as an instrument to measure outcome. For example, the JOA score does not include patients’ satisfaction, disability, handicaps, or general health (physical and mental health), which can be affected by cervical myelopathy.
A more specific outcome measure, in which patients’ satisfaction, disability, handicaps, and general health can be evaluated, is necessary for cervical myelopathy. The first and most important long-term goal of the treatment for patients with cervical myelopathy is to improve their health status and QOL. Evaluation of QOL should include comprehensive assessment of the patient’s health status specific to the disorder, such as evaluation of pain, a working status, and the patient’s life satisfaction.6 The second goal is to evaluate the status of decompression of the spinal cord and nerve roots, the alignment of the cervical spine, bony fusion in patients undergoing arthrodesis, adjacent segment diseases, and the range of motion in the cervical spine. These factors relate directly to the surgical strategy and can be easily evaluated by spine surgeons. However, these factors are not necessarily associated with the first goal of QOL improvement. The third goal is to develop an outcome measure to objectively assess the relationship between medical costs and the quality of a treatment. Therefore, the evaluation method that forms the basis of the instrument’s items should be related to the outcome measures for patients with cervical myelopathy.
Based on current knowledge about the outcome measures of medical care, there is an urgent need to develop a new JOA score to evaluate cervical myelopathy. The purpose of this study was to develop a new outcome measure for patients with cervical myelopathy that can be used and understood by patients and health professionals. It is also important that this new outcome measure uses objective items, can be used clinically, and attaches a high value to respect for the patient. In this study (Part 1), the members of the Subcommittee on Evaluation for Low Back Pain and Cervical Myelopathy, who belonged to the Clinical Outcomes Committee of the Japanese Orthopaedic Association, devised a new questionnaire to evaluate the functional capacity of the cervical spine, physical function of the upper and lower extremities, and bladder function, which might be disturbed by cervical myelopathy. The authors listed, in the original questionnaire, items that were thought to be related to symptoms of cervical myelopathy. Using this original questionnaire, which was thought to be related to symptoms of cervical myelopathy, and the Medical Outcome Study Short-Form 36-Item Health Survey (SF-36, Japanese version),7 which is used to evaluate health-related QOL, the authors performed a primary survey on healthy volunteers and patients with cervical myelopathy. The authors analyzed the responses to the questionnaire to devise a self-administered questionnaire, composed of a short list of the original questionnaire items, which fits into two pages of A4-size paper.
Methods
The Clinical Outcomes Committee of Japanese Orthopaedic Association conducted this study together with various medical institutions with the aim of preparing an instrument to objectively evaluate patients with cervical myelopathy. This study was conducted in eight university hospitals and their affiliated hospitals from February to May 2002. A member of the Subcommittee on Low Back Pain and Cervical Myelopathy Evaluation from each hospital administered the questionnaire to more than 30 patients with cervical myelopathy.
Questionnaire
The questionnaire included 77 items (Tables 1, 2). Forty-one questions, which were originally listed by the authors, were for evaluation of the physical function of the cervical spine and spinal cord (Table 1). A respondent recalled his or her physical condition during the last week and circled the item number of each of the questions that best applied to his or her condition. If a respondent’s condition changed depending on the day or the time, he or she circled the item number of “your worst condition.” Each item in this questionnaire related to items C-1 to C-41. The SF-36 was used to examine health-related QOL (Table 2) and related items QOL-1 to QOL-11-4. The JOA score revised in 1994 (revised 17-point method; Table 3),8 in which the evaluation of nerve root function was supplemented, was used and evaluated by a medical professional in the present study.
Survey of patients with cervical myelopathy
Patients answered each question by themselves. This study included patients with cervical myelopathy secondary to cervical disc herniation, spondylosis, ossification of the posterior longitudinal ligament, calcification of the ligament flavum, spinal cord tumor, and developmental spinal canal stenosis. Patients with the following disorders were excluded: cervical spondylotic amyotrophy, cervical radiculopathy, disorders of the upper cervical spine such as atlantoaxial subluxation, spinal tumor, vascular lesions of the cervical spinal cord, cervical hemangioma, syringomyelia, multiple sclerosis, motor neuron disease, myelitis, and spinal cord injury. Patients with disturbances of the central nervous system such as cerebral infarction, combined cervical and thoracic spine lesions, orthopedic disorders other than cervical myelopathy, and cognitive disorders, and patients who could not complete the questionnaire because of defects of the arm, fingers, or foot, were also excluded. Patients whose condition resulted from occupational accidents, traffic accidents, or injuries were excluded.
The investigation period was 4 weeks from the start of the present study at each institution. All patients were asked to participate in the survey and were told that the questionnaire would be used to develop a new JOA score. Only patients who agreed to join the study answered the questionnaire.
Survey of healthy volunteers
Healthy volunteers were recruited at each institution during the same period. They were self-supporting and required no medical assistance. Individuals being treated with alternative medicine such as acupuncture, cautery, massage, or chiropractic were included.
The healthy volunteers were grouped by sex and age by decade from 20 to 80 years. More than 15 healthy individuals from each institution within each age decade and from each sex were surveyed. Medical professionals were excluded from participating as healthy volunteers.
This study design was reviewed and approved by the institutional review board in each institution, and informed consent was obtained from each patient or volunteer.
Selection of questions to develop the short list of questions
After analysis of the answers from patients and volunteers, the authors excluded irrelevant questions using the following criteria:
-
1.
A question for which 80% of answers were concentrated on one choice.
-
2.
A question whose answer was highly correlated with that of other questions. For this analysis, the Spearman’s correlation coefficients for the distribution of answers to each question were used. P≥ 0.45 indicates a significant correlation.
-
3.
A question that could be explained by other questions.
-
4.
A question for which the distribution of the answers obtained from the patients was not different from that obtained from the normal volunteers.
-
5.
Discriminant analysis was used to examine the ratio of discrimination when one of the residual items obtained from these analyses above was selected as an objective parameter and the others as explanatory variables. Using this analysis, the minimal ratio of discrimination for each choices and the ratio of discrimination through all choices were calculated. To evaluate the agreement of these discriminations, a κ value was used. Each item was evaluated if it was excluded statistically. If the minimal ratio of discrimination reached more than 70% in the choice of the answers for any question items, the selected question items could be deleted.
Statistical analysis
Data were analyzed using STATISTICA for Windows (1988) (StatSoft, Tulsa, OK, USA) and SPSS software (version 12; Chicago, IL, USA). Spearman’s correlation coefficient, discriminant analysis, and χ2 analysis were used to make a short list of questions as an outcome measure for patients with cervical myelopathy. P < 0.05 was considered significant.
Results
Two hundred and fifty patients with cervical myelopathy and 216 healthy volunteers were enrolled in the study. The patients comprised 164 men and 86 women, and the healthy volunteers 96 men and 120 women. Cervical myelopathy was secondary to a herniated disc in 33 patients, spondylosis in 146 patients, ossification of the posterior longitudinal ligament in 59 patients, calcification of the ligament flavum in 2 patients, spinal cord tumor in 7 patients, and combined disorders in 3. Table 4 shows the age and sex distribution of patients and healthy volunteers. Although enrollment of more than 15 healthy volunteers within each age decade and from each sex was planned, more than 20 healthy individuals were distributed into each age decade except for those over 80 years. The authors then excluded individuals with any complications from another orthopedic disorder, giving 233 patients and 213 volunteers whose data were analyzed.
The distribution of the revised JOA score is shown in Table 5 and revealed that patients with mild to severe myelopathy were involved in the present study. The distribution of this patients’ group was not anomalous as a group of patients with cervical myelopathy. Most of volunteers had a normal score.
The distribution of the answers to the questions that were designed to evaluate the physical functions of the cervical spine and the spinal cord was evaluated. The questions that elicited no answer or “I am not sure” from more than 5% of the participants were C-8, C-23, C-24, C-25, C-26, and C-41 in the patients, and C-23, C-24, and C-41 in the healthy volunteers. The volunteers answered more than 80% of questions with the choice “I can do it without difficulty,” except questions C-8, C-30, and C-33. Taking question C-8 (“Can you eat a meal using a spoon or a fork with your left hand?”) together with question C-7 (the same question but with the other hand), as an indicator of hand dominance, increased the normal response rate to more than 90%. The question C-30 (“How often do you go to the bathroom [to void urine] at night?”) had a concentrated response of more than 75% in the normal volunteer group. Responses to the question C-33 (about the number of evacuations or constipation) did not differ significantly between the patients and healthy volunteers. (χ2 analysis, P = 0.20) In the patients, more than 80% of the answers to the questions C-11, C-12, C-15, C-17, C-27, C-29, and C-34 were concentrated on one option, “I can do it without difficulty.” About 80% of the answers to the questions C-38, C-39 and C-40 were concentrated on one option, “I can do it without difficulty.” Based on these findings, the authors excluded items C-11, C-12, C-15, C-17, C-27, C-29, and C-34 from the questionnaire.
The distribution of answers to the questions relating to QOL was also statistically evaluated. No option elicited a response of less than 5%. There were no similarities in the distribution of the answers to the questions about QOL between the patients and volunteers. (χ2 analysis, P < 0.50). In patients, no questions had an answer that concentrated on one option.
When the items, which were correlated with one another, were picked up on the table obtained from the analysis using the Spearman’s correlation coefficients, the questions related to the physical functions of the cervical spine and the spinal cord were divided into four groups: C-1 to C-10 (10 items), C-11 to C-14 (4 items), C-16 to C-26 (11 items), and C-35 to C-40 (6 items). Some questions within each group correlated significantly with one another. The questions in different groups also correlated significantly, such as C-1 to C-5 with C-18 to C-22, C-10 with C-18 to C-22, and C-29 with C-32. The questions related to QOL were also divided into four groups: QOL-3-1 to QOL-4-4 (14 items, which were related to daily activities); QOL-4-1 to QOL-8 (10 items); QOL-8 to QOL-9-9 (10 items); and QOL-11-1, QOL-11-2, and QOL-11-4 (3 items). Some questions within each group correlated significantly. The questions in different groups also correlated significantly, such as QOL-1 with QOL-2; QOL-4-4 with QOL-9-8; QOL-10 with QOL-4-1 to QOL-6; and QOL-11-4 with QOL-1, QOL-9-1, QOL-9-8, and QOL-10. For the questions related to the physical functions of the cervical spine and the spinal cord, significant correlations were observed between C-1 and QOL-3-7, QOL-3-9 and QOL-3-10; between C-4 and QOL-3-4 and QOL-3-7, between C-5 and QOL-3-7, between C-16 and QOL-3-2 to QOL-4-4; and between C-18 to C-22, C-25, C-26 and QOL-3-1 to QOL-4-4. Utilizing the analysis of the Spearman’s correlation coefficients, 1 item of questions that were correlated with each other was selected.
Table 6 summarizes all reasons for excluding or including a certain question in the final questionnaire. Fifty-three items were excluded. Thirteen items from the questions about the physical functions of the cervical spine and the spinal cord and 11 items from SF-36 were selected for the final outcome measure questionnaire for cervical myelopathy.
Table 7 shows the ratios of discrimination obtained from discriminant analysis and κ value. The question items, which can be excluded for multivariate using discriminant analysis, were reviewed, but all items of questions were retained. Because the minimal ratio of discrimination did not reach more than 70% in the choice of the answers for any question items, any selecte d question items could not substitute for other items.
Discussion
Previous outcome measures to evaluate recovery of the neurological function in patients with cervical myelopathy included a one-dimensional scale, which was used only by medical professionals and which rated a certain neurological function using descriptors such as excellent, good, fair, and poor.9–11 This type of one-dimensional scale of neural function cannot be used to evaluate more complex dimensions such as activities of daily living and work capacity, and may be inadequate as an outcome measure for patients with cervical myelopathy. Nurick’s grading system has been used to evaluate surgical outcomes throughout the world.12 However, Nurick’s system cannot be used to evaluate physical function of the upper extremities and cannot be used with older, retired patients because it involves questions about job-related activities.
The JOA score may be a better method to evaluate the neurological function of patients with cervical myelopathy because it considers the pathophysiology of cervical myelopathy and provides a quantitative measure of outcomes (i.e., a score). Only one multicenter study, by Yonenobu et al.,13 has demonstrated the high inter- and intraobserver reliability of the JOA score. However, there are few reports about the sensitivity, feasibility, validity, and responsibility of the JOA score. In addition, the JOA score attaches importance to the physical function of the upper and lower extremities and bladder dysfunction but does not include the physical functions of the cervical spine, including the range of motion of the neck, pain, or stiff neck; patients’ satisfaction; disability; social disability; or QOL.
Because of such problems associated with the JOA score, the authors believe that a better outcome measure is needed to evaluate patients with cervical myelopathy. The authors first devised a questionnaire that focused on the physical functions of the cervical spine and the spinal cord and combined it with the SF-36 to evaluate QOL. The authors administered this to patients with cervical myelopathy and healthy volunteers at the participating hospitals. The authors then used various statistical tools to make an appropriate questionnaire. 14,15 The authors excluded questions for which more than 80% of the answers were concentrated on one option, questions that correlated highly with other questions (P≥ 0.45), questions that could be explained by more than one question, or questions for which distributions of the answers were not different between the patients and healthy volunteers. The authors were able to develop a self-administered questionnaire of 24 items to provide a better outcome measure for patients with cervical myelopathy. Discriminant analysis demonstrated that none of the 24 items gave a minimal ratio of more than 70%, and therefore all 24 questions were retained. The questionnaire was then printed on two pages of A4-size paper. Patients can complete the questionnaire in about 10 to 20 minutes.
Some questions asked about the identical function in the right and left hands, arms (e.g., C-2 and C-3, C-7 and C-8, C-11 and C-12, and C-13 and C-14), feet (e.g., C-21 and C-22, and C-23 and C-24), and sidedness (e.g., C-39 and C-40) separately. With these questions, the authors can identify the dominant hand and difference between the right and left sides of the body caused by asymmetry in the severity of symptoms. In the candidates of questions for an outcome measure, for item C-7, the authors changed the words from “right hand” to “dominant hand” and for item C-13, the authors changed the sentence from “Can you raise your right arm?” to “Can you raise your arm? (Answer about the weaker one.)”. In question C-21, the authors also changed the options of answers to (1) “I can hardly do it with either leg,” (2) “I cannot continue standing for more than 10 seconds on the weaker leg”, and (3) “I can continue standing on either leg for more than 10 seconds.” In question C-41 (“Can you turn your head when you back your car?”) about 22% of patients and 10% of normal volunteers responded “I am not sure” or “I do not drive”. Because some older patients no longer drive a car, the authors provided an alternative question to C-41, “While in the sitting position, can you turn your head toward the person who is seated behind you and speak to him/her while looking him/her in the face?”
Twenty-four items and one alternative remained as candidates for the final questionnaire (Table 8). Further studies are necessary to demonstrate that the alternative question can be used to replace the question C-41 by evaluating the reliability and responsiveness of the questionnaire with the alternative question. The authors will continue to elucidate the efficacy of this questionnaire through studies regarding the visual analogue scale for pain, neck stiffness, and numbness, and the patients’ satisfaction in patients with cervical myelopathy. This new self-administered questionnaire may be effective and easy to use in clinical practice. However, because no objective parameter for each question has been standardized yet, the authors plan to combine and further assess this information using factor analysis.
This new self-administered questionnaire can be used to evaluate the outcomes in patients with cervical myelopathy more efficiently and will be helpful to identify the most appropriate treatment, medical services, and improved medical skills.
References
Japanese Orthopaedic Association score for cervical spondylotic myelopathy. J Jpn Orthop Assoc 1975; 99: prefatory note (in Japanese)
K Hirabayashi J Miyakawa K Satomi T Maruyama K Wakano (1981) ArticleTitleOperative results and postoperative progression of ossification among patients with ossification of cervical posterior longitudinal ligament Spine 6 354–4 10.1097/00007632-198107000-00005 Occurrence Handle10.1097/00007632-198107000-00005 Occurrence Handle1:STN:280:DyaL38%2FhslGkuw%3D%3D Occurrence Handle6792717
EC Benzel J Lancon L Kesterson T Hadden (1991) ArticleTitleCervical laminectomy and dentate ligament section for cervical spondylotic myelopathy J Spinal Disord 4 286–95 Occurrence Handle10.1097/00002517-199109000-00005 Occurrence Handle1:STN:280:DyaK387pvFKnsA%3D%3D Occurrence Handle1802159
C Hamburger A Buttner E Uhl (1997) ArticleTitleThe cross-sectional area of the cervical spinal canal in patients with cervical spondylotic myelopathy. Correlation of preoperative and postoperative area with clinical symptoms Spine 22 1990–5 10.1097/00007632-199709010-00009 Occurrence Handle10.1097/00007632-199709010-00009 Occurrence Handle1:STN:280:DyaK2svltFGrsQ%3D%3D Occurrence Handle9306528
JK Houten PR Cooper (2003) ArticleTitleLaminectomy and posterior cervical plating for multilevel cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome Neurosurgery 52 1081–8 10.1227/01.NEU.0000057746.74779.55 Occurrence Handle10.1227/01.NEU.0000057746.74779.55 Occurrence Handle12699550
GL Engel (1980) ArticleTitleThe clinical application of the biopsychosocial model Am J Psychiatry 137 535–44 Occurrence Handle1:STN:280:DyaL3c7nt1yqtg%3D%3D Occurrence Handle7369396
S Fukuhara Y Suzugamo S Bito K Kurokawa (2001) Manual of SF-36 Japanese version 1.2 Public Health Research Foundation Tokyo
Revised Japanese Orthopaedic Association scores for cervical myelopathy. J Jpn Orthop Assoc 1994; 68:490–503 (in Japanese)
LH Riley SuffixJr RA Robinson KA Johnson AE Walker (1969) ArticleTitleThe results of anterior interbody fusion of the cervical spine J Neurosurg 30 127–33 Occurrence Handle10.3171/jns.1969.30.2.0127 Occurrence Handle5780880
B Guidetti A Fortuna (1969) ArticleTitleLong-term results of surgical treatment of myelopathy due to cervical spondylosis J Neurosurg 30 714–21 10.3171/jns.1969.30.6.0714 Occurrence Handle10.3171/jns.1969.30.6.0714 Occurrence Handle1:STN:280:DyaF1M3ht1yqtw%3D%3D Occurrence Handle5787848
H Arnold Feldmannu U Mibler (1993) ArticleTitleChronic spondylogenic cervical myelopathy. A critical evaluation of surgical treatment after early and long-term follow-up Neurosurg Rev 16 105–9 10.1007/BF00258239 Occurrence Handle10.1007/BF00258239 Occurrence Handle1:STN:280:DyaK3szkslyitA%3D%3D Occurrence Handle8345902
S Nurick (1972) ArticleTitleThe pathogenesis of the spinal cord disorder associated with cervical spondylosis Brain 95 87–100 10.1093/brain/95.1.87 Occurrence Handle10.1093/brain/95.1.87 Occurrence Handle1:STN:280:DyaE387ns1artQ%3D%3D Occurrence Handle5023093
K Yonenobu K Abumi K Nagata E Taketomi K Ueyama (2001) ArticleTitleInterobserver and intraobserver reliability of the Japanese Orthopaedic Association Scoring system for evaluation of cervical compression myelopathy Spine 26 1890–5 10.1097/00007632-200109010-00014 Occurrence Handle10.1097/00007632-200109010-00014 Occurrence Handle1:STN:280:DC%2BD3MrivV2jug%3D%3D Occurrence Handle11568701
DL Streiner GR Norman (1995) Health measurement scales: a practical guide to their development and use EditionNumber2nd ed Oxford University Press Oxford
PW Stratford JM Binkley (1997) ArticleTitleMeasurement properties of RM-18: a modified version of the Roland–Morris disability scale Spine 22 2416–21 10.1097/00007632-199710150-00018 Occurrence Handle10.1097/00007632-199710150-00018 Occurrence Handle1:STN:280:DyaK1c%2Fhs1yntg%3D%3D Occurrence Handle9355224
Author information
Authors and Affiliations
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Fukui, M., Chiba, K., Kawakami, M. et al. An outcome measure for patients with cervical myelopathy: Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): Part 1. J Orthop Sci 12, 227–240 (2007). https://doi.org/10.1007/s00776-007-1118-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00776-007-1118-1